Meanwhile, we cultured the extracted CD103+CD8+ TRMs and then passed them through adoptive therapy and found that the tumor volume was smaller in the CD103+CD8+ TRMs treatment group (Fig. 4C). The gene discussed is CD8A; the disease is neoplasm.